Company
Telo Therapeutics
Also known as Telo Therapeutics, Inc
- Business model
- B2B
- Legal name
- Telo Therapeutics, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Deploying targeted protein degradation to unlock the full potential of nuclear transport inhibitors in oncology Telo Therapeutics is an oncology therapeutics company developing innovative targeted therapies to treat patients with cancers refractory to existing medicines. Our mission is to dramatically improve survival and well-being in cancer patients who have run out of treatment options. Telo Therapeutics
Funding snapshot
- Total raised
- $4.7MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $4.7M2021-06-09
Funding rounds
- Round, 2021
- $4.7M2021-06-09, SEC form D sold, 12 investors
Loading relationship preview